Publications

  1. Tan WW, Heckman MG, Vishnu P, Crook JE, Younkin LH, Covil EG, Ferman TJ, Graff-Radford NR, Younkin SG, Smallridge RC, Wehle MJ, Buskirk SJ. Effect of leuprolide on serum amyloid-beta peptide levels and memory in patients with prostate cancer with biochemical recurrence. Urology. 2013 Jan; 81(1):150-4. 2292432
    View PubMed
  2. Peterson JL, Buskirk SJ, Heckman MG, Parker AS, Diehl NN, Tzou KS, Paryani NN, Ko SJ, Daugherty LC, Vallow LA, Pisansky TM. Evaluation of Serum Calcium as a Predictor of Biochemical Recurrence following Salvage Radiation Therapy for Prostate Cancer. ISRN Oncol. 2013; 2013:239241. Epub 2013 Mar 31. 2318509
    View PubMed
  3. Heckman MG, Parker AS, Wu KJ, Hilton TW, Ko SJ, Pisansky TM, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer. Prostate. 2012 Dec 1; 72(16):1757-66. Epub 2012 Apr 18. 2240773
    View PubMed
  4. Panjala C, Nguyen JH, Al-Hajjaj AN, Rosser BA, Nakhleh RE, Bridges MD, Ko SJ, Buskirk SJ, Kim GP, Harnois DM. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma. Liver Transpl. 2012 May; 18(5):594-601. 2209925
    View PubMed
  5. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012; 7:174. Epub 2012 Oct 22. 2287846
    View PubMed
  6. Kowalchik KV, Vallow LA, McDonough M, Thomas CS, Heckman MG, Peterson JL, Adkisson CD, Serago C, Buskirk SJ, McLaughlin SA. The role of preoperative bilateral breast magnetic resonance imaging in patient selection for partial breast irradiation in ductal carcinoma in situ. Int J Surg Oncol. 2012; 2012:206342. Epub 2012 May 13. 2252567
    View PubMed
  7. Parker AS, Heckman MG, Sheinin Y, Wu KJ, Hilton TW, Diehl NN, Pisansky TM, Schild SE, Kwon ED, Buskirk SJ. Evaluation of B7-H3 expression as a biomarker of biochemical recurrence after salvage radiation therapy for recurrent prostate cancer. Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79(5):1343-9. Epub 2010 Jul 02. 2105150
    View PubMed
  8. Tzou K, Tan WW, Buskirk S. Treatment of men with rising prostate-specific antigen levels following radical prostatectomy. Expert Rev Anticancer Ther. 2011 Jan; 11(1):125-36. 2136032
    View PubMed
  9. Bernard JR Jr, Buskirk SJ, Heckman MG, Diehl NN, Ko SJ, Macdonald OK, Schild SE, Pisansky TM. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. Int J Radiat Oncol Biol Phys. 2010 Mar 1; 76(3):735-40. Epub 2009 May 21. 1988644
    View PubMed
  10. Bernard JR Jr, Vallow LA, DePeri ER, McNeil RB, Feigel DG, Amar S, Buskirk SJ, Perez EA. In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: the mayo clinic in Florida experience. Breast J. 2010 Mar-Apr; 16(2):118-26. Epub 2010 Jan 29. 1985069
    View PubMed
  11. Parker AS, Heckman MG, Wu KJ, Crook JE, Hilton TW, Pisansky TM, Bernard JR, Schild SE, Khor LY, Hammond EH, Pollack A, Buskirk SJ. Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Dec 1; 75(5):1364-70. Epub 2009 May 21. 1944187
    View PubMed
  12. Peterson JL, Buskirk SJ, Heckman MG, Crook JE, Ko SJ, Wehle MJ, Igel TC, Prussak KA, Pisansky TM. Late toxicity after postprostatectomy salvage radiation therapy. Radiother Oncol. 2009 Nov; 93(2):203-6. Epub 2009 Sep 18. 1970515
    View PubMed
  13. Jain AK, Vallow LA, Gale AA, Buskirk SJ. Does three-dimensional external beam partial breast irradiation spare lung tissue compared with standard whole breast irradiation? Int J Radiat Oncol Biol Phys. 2009 Sep 1; 75(1):82-8. Epub 2009 Feb 21. 1925529
    View PubMed
  14. Moore LF, Kransdorf MJ, Buskirk SJ, O'Connor MI, Menke DM. Radiation-induced pseudotumor following therapy for soft tissue sarcoma. Skeletal Radiol. 2009 Jun; 38(6):579-84. Epub 2009 Feb 17. 1925077
    View PubMed
  15. Gale AA, Jain AK, Vallow LA, Serago CF, Buskirk SJ, Heckman MG. Cardiac dose evaluation for 3-dimensional conformal partial breast irradiation compared with whole breast irradiation. J Appl Clin Med Phys. 2009; 10(1):2868. Epub 2009 Jan 14. 1925072
    View PubMed
  16. Peterson JL, Vallow LA, Hines SL, Buskirk SJ. Ductal carcinoma in situ of the breast. Oncology Reviews. 2009; 3(4):237-46. 1983295
    View PubMed
  17. Wong WW, Buskirk SJ, Schild SE, Prussak KA, Davis BJ. Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation. J Urol. 2006 Nov; 176(5):2020-4. 1789269
    View PubMed
  18. Buskirk SJ, Pisansky TM, Schild SE, Macdonald OK, Wehle MJ, Kozelsky TF, Collie AC, Ferrigni RG, Myers RP, Prussak KA, Heckman MG, Crook JE, Parker AS, Igel TC. Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system. J Urol. 2006 Sep; 176(3):985-90. 1874296
    View PubMed
  19. Serago CF, Buskirk SJ, Igel TC, Gale AA, Serago NE, Earle JD. Comparison of daily megavoltage electronic portal imaging or kilovoltage imaging with marker seeds to ultrasound imaging or skin marks for prostate localization and treatment positioning in patients with prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Aug 1; 65(5):1585-92. 1775791
    View PubMed
  20. Buskirk SJ, Kraft KJ, Witt NJ, Scheuer AK, Gianforti BL, DeGuzman ML, Hunter CA, Guida M, Serago CF, Schild SE, Collie AC. Salvage radiotherapy for patients with increasing prostate-specific antigen levels after radical prostatectomy: Evaluation of the role of retrograde urethrography. Journal of Radiotherapy in Practice. 2006; 5(2):117-20. 1972076
    View PubMed
  21. Buskirk SJ, Pinkstaff DM, Petrou SP, Wehle MJ, Broderick GA, Young PR, Weigand SD, O'Brien PC, Igel TC. Acute urinary retention after transperineal template-guided prostate biopsy. Int J Radiat Oncol Biol Phys. 2004 Aug 1; 59(5):1360-6. 1653819
    View PubMed
  22. Maples WJ, Buskirk SJ. Multimodality treatment of upper extremity bone and soft tissue sarcomas. Hand Clin. 2004 May; 20(2):221-5. 1653051
    View PubMed
  23. Wehle MJ, Lisson SW, Buskirk SJ, Broderick GA, Young PR, Igel TC. Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma. Mayo Clin Proc. 2004 Mar; 79(3):314-7. 1639102
    View PubMed
  24. Reed D, Wallner K, Merrick G, Buskirk S, True L. Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology. 2003 Oct; 62(4):683-8. 1517823
    View PubMed
  25. Serago CF, Chungbin SJ, Buskirk SJ, Ezzell GA, Collie AC, Vora SA. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Aug 1; 53(5):1130-8. 1315107
    View PubMed
  26. Buskirk SJ, Pisansky TM, Atkinson EJ, Schild SE, O'Brien PC, Wolfe JT, Zincke H. Lymph node-positive prostate cancer: evaluation of the results of the combination of androgen deprivation therapy and radiation therapy. Mayo Clin Proc. 2001 Jul; 76(7):702-6. 1005243
    View PubMed
  27. Woodward TA, Menke DM, Buskirk SJ. Solitary pelvic nodule: diagnosis of metastatic prostate cancer by endoscopic ultrasound-guided, fine-needle aspiration. Am J Gastroenterol. 2000 Sep; 95(9):2372-3. 1012475
    View PubMed
  28. Pisansky TM, Kozelsky TF, Myers RP, Hillman DW, Blute ML, Buskirk SJ, Cheville JC, Ferrigni RG, Schild SE. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 2000 Mar; 163(3):845-50. 128445
    View PubMed
  29. Serago CF, Buskirk SJ, Karstaedt N, Wehle M, Igel TC, Casale HE. A comparison of prostate iodine-125 seed dose planning using computed tomography and ultrasound imaging. Journal of Brachytherapy International. 2000; 16(2):111-116. 1012288
    View PubMed
  30. Foote RL, Buskirk SJ, Grado GL, Bonner JA. Has radiotherapy become too expensive to be considered a treatment option for early glottic cancer? Head Neck. 1997 Dec; 19(8):692-700. 1016691
    View PubMed
  31. Foo ML, Gunderson LL, Bender CE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1997 Nov 1; 39(4):929-35. 1015630
    View PubMed
  32. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol. 1997 Mar; 15(3):1239-43. 101929
    View PubMed
  33. Schild SE, Buskirk SJ, Wong WW, Halyard MY, Swanson SK, Novicki DE, Ferrigni RG. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. J Urol. 1996 Nov; 156(5):1725-9. 1027179
    View PubMed
  34. Buskirk SJ, Schild SE, Durr ED, Robinow JS, Bock FF, Wolfe JT, Tomera KM, Ferrigni RG. Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, no prostate cancer. Mayo Clin Proc. 1996 Mar; 71(3):242-248. 1026597
    View PubMed
  35. Foote RL, Grado GL, Buskirk SJ, Olsen KD, Bonner JA, Earle JD, Kasperbauer JL, McCaffrey TV, Suman VJ. Radiation therapy for glottic cancer using 6-MV photons. Cancer. 1996 Jan 15; 77(2):381-6. 95258
    View PubMed
  36. Olsen KD, Caruso M, Foote RL, Stanley RJ, Lewis JE, Buskirk SJ, Frassica DA, DeSanto LW, O'Fallon WM, Hoverman VR. Primary head and neck cancer. Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement. Arch Otolaryngol Head Neck Surg. 1994 Dec; 120(12):1370-4. 89454
    View PubMed
  37. Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Laryngectomy alone for T3 glottic cancer. Head Neck. 1994 Sep-Oct; 16(5):406-12. 88568
    View PubMed
  38. Schild SE, Wong WW, Grado GL, Buskirk SJ, Robinow JS, Frick LM, Ferrigni RG. Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy. Mayo Clin Proc. 1994 Jul; 69(7):613-9. 1033668
    View PubMed
  39. Foote RL, Hilgenfeld RU, Kunselman SJ, Schaid DJ, Buskirk SJ, Grado GL, Earle JD. Radiation therapy for squamous cell carcinoma of the tonsil. Mayo Clin Proc. 1994 Jun; 69(6):525-31. 87644
    View PubMed
  40. Foote RL, Schild SE, Thompson WM, Buskirk SJ, Olsen KD, Stanley RJ, Kunselman SJ, Schaid DJ, Grill JP. Tonsil cancer. Patterns of failure after surgery alone and surgery combined with postoperative radiation therapy. Cancer. 1994 May 15; 73(10):2638-47. 88861
    View PubMed
  41. Schild SE, Scheithauer BW, Schomberg PJ, Hook CC, Kelly PJ, Frick L, Robinow JS, Buskirk SJ. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer. 1993 Aug 1; 72(3):870-80. 84256
    View PubMed
  42. Foote RL, Olsen KD, Davis DL, Buskirk SJ, Stanley RJ, Kunselman SJ, Schaid DJ, DeSanto LW. Base of tongue carcinoma: patterns of failure and predictors of recurrence after surgery alone. Head Neck. 1993 Jul-Aug; 15(4):300-7. 85603
    View PubMed
  43. Thompson WM, Foote RL, Olsen KD, Schaid DJ, Grado GL, Buskirk SJ, Earle JD. Postoperative irradiation for tonsillar carcinoma. Mayo Clin Proc. 1993 Jul; 68(7):665-9. 83742
    View PubMed
  44. Perniciaro CV, Buskirk SJ. Extramammary Paget's disease treated with radiotherapy. Journal of Dermatological Treatment. 1993; 3:164-165. 1028656
  45. Shaw EG, Brindle JS, Creagan ET, Foote RL, Trastek VF, Buskirk SJ. Locally recurrent non-small-cell lung cancer after complete surgical resection. Mayo Clin Proc. 1992 Dec; 67(12):1129-33. 1040710
    View PubMed
  46. Foote RL, Olsen KD, Kunselman SJ, Schaid DJ, Buskirk SJ, Grado GL, Earle JD. Early-stage squamous cell carcinoma of the glottic larynx managed with radiation therapy. Mayo Clin Proc. 1992 Jul; 67(7):629-36. 80151
    View PubMed
  47. Schild SE, Foote RL, Buskirk SJ, Robinow JS, Bock FF, Cupps RE, Earle JD. Results of radiotherapy for chemodectomas. Mayo Clin Proc. 1992 Jun; 67(6):537-40. 1040344
    View PubMed
  48. Buskirk SJ, Gunderson LL, Schild SE, Bender CE, Williams HJ Jr, McIlrath DC, Robinow JS, Tremaine WJ, Martin JK Jr. Analysis of failure after curative irradiation of extrahepatic bile duct carcinoma. Ann Surg. 1992 Feb; 215(2):125-31. 1313769
    View PubMed
  49. Schild SE, Robinow JS, Casale HE, Bellefontaine LP, Buskirk SJ. Radiotherapy treatment planning for prostate cancer in patients with prosthetic hips. Med Dosim. 1992; 17(2):83-6. 1039969
  50. Schild SE, Buskirk SJ, Robinow JS, Tomera KM, Ferrigni RG, Frick LM. The results of radiotherapy for isolated elevation of serum PSA levels following radical prostatectomy. Int J Radiat Oncol Biol Phys. 1992; 23(1):141-5. 1040777
    View PubMed
  51. Schild SE, Buskirk SJ, Robinow JS. Prostate cancer: retrograde urethrography to improve treatment planning for radiotherapy. Radiology. 1992; 181:885-887. 1040780
  52. Schild SE, Buskirk SJ, Frick LM, Cupps RE. Radiotherapy for large symptomatic hemangiomas. Int J Radiat Oncol Biol Phys. 1991 Aug; 21(3):729-35. 1038264
    View PubMed
  53. Foote RL, Buskirk SJ, Stanley RJ, Grambsch PM, Olsen KD, DeSanto LW, Earle JD, Weiland LH. Patterns of failure after total laryngectomy for glottic carcinoma. Cancer. 1989 Jul 1; 64(1):143-9. 1046683
    View PubMed
  54. Foote RL, Garretson BR, Schomberg PJ, Buskirk SJ, Robertson DM, Earle JD. External beam irradiation for retinoblastoma: patterns of failure and dose-response analysis. Int J Radiat Oncol Biol Phys. 1989 Mar; 16(3):823-30. 1046293
    View PubMed
  55. Martenson JA Jr, Buskirk SJ, Ilstrup DM, Banks PM, Evans RG, Colgan JP, Earle JD. Patterns of failure in primary testicular non-Hodgkin's lymphoma. J Clin Oncol. 1988 Feb; 6(2):297-302. 64830
    View PubMed
  56. Buskirk SJ, Schray MF, Podratz KC, Lee RA, Stanhope CR, Gaffey TA, Weber FC, Earle JD, Naessens JM, Malkasian GD. Ovarian dysgerminoma: a retrospective analysis of results of treatment, sites of treatment failure, and radiosensitivity. Mayo Clin Proc. 1987 Dec; 62(12):1149-57. 63250
    View PubMed
  57. Martenson JA Jr, Gunderson LL, Buskirk SJ, Nagorney DM, Martin JK, May GR, Bender CE, Tremaine WJ. Hepatic duct stricture after radical radiation therapy for biliary cancer: recurrence or fibrosis? Mayo Clin Proc. 1986 Jul; 61(7):530-6. 58421
    View PubMed
  58. Blair TJ, Evans RG, Buskirk SJ, Banks PM, Earle JD. Radiotherapeutic management of primary thyroid lymphoma. Int J Radiat Oncol Biol Phys. 1985 Feb; 11(2):365-70. 1050330
    View PubMed
  59. Buskirk SJ, Gunderson LL, Adson MA, Martinez A, May GR, McIlrath DC, Nagorney DM, Edmundson GK, Bender CE, Martin JK Jr. Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1984 Nov; 10(11):2013-23. 1119593
    View PubMed
  60. Buskirk SJ, Evans RG, Banks PM, O'Connell MJ, Earle JD. Primary lymphoma of the testis. Int J Radiat Oncol Biol Phys. 1982 Oct; 8(10):1699-703. 1115491
    View PubMed
  61. Buskirk SJ, Evans RG, Farrow GM, Earle JD. Primary retroperitoneal seminoma. Cancer. 1982 May 1; 49(9):1934-6. 1114250
    View PubMed